23andMe is paying up to $10,000 person after customers information was compromised, but the deadline is near. Here's how to claim your cash.

Did you spit in a tube for 23andMe? If so, your genetic data may soon be handed over to a new company — Regeneron. Just four years ago, when 23andMe went public, the company was valued at $6 billion.

After 23andMe announced that it’s headed to bankruptcy court, it’s unclear what happens to the mass of sensitive genetic data that it holds.

A breach announced in 2023 of 23andMe's databases resulted in the theft of personal information of roughly 6.4 million U.S.

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

New York and other states filed a lawsuit seeking to block 23andMe, the bankrupt genetic testing firm, from selling millions of Americans' genetic data to the highest bidder. A total of 28 state ...

The genetic testing company is addressing the fallout from a 2023 credential stuffing attack. Here's how to protect yourself.

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy auction.

23andMe, a popular direct-to-consumer genetic testing company, made headlines after its CEO pledged to help reunite the more than 2,300 children separated from their parents at the U.S.’s southern ...

23andMe was once a high-flying biotech firm. It collected a trove of DNA data on millions of its customers, and then it went bust. The fate of that data has been at the center of a legal battle over ...